Related Experiment Video
Updated: May 30, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Knockdown of survivin (BIRC5) causes apoptosis in neuroblastoma via mitotic catastrophe
Fieke Lamers1, Ida van der Ploeg, Linda Schild
1Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO Box 22700, 1105 AZ Amsterdam, The Netherlands.
Abstract:
BIRC5 (survivin) is one of the genes located on chromosome arm 17q in the region that is often gained in neuroblastoma. BIRC5 is a protein in the intrinsic apoptotic pathway that interacts with XIAP and DIABLO leading to caspase-3 and caspase-9 inactivation. BIRC5 is also involved in stabilizing the microtubule-kinetochore dynamics. Based on the Affymetrix mRNA expression data, we here show that BIRC5 expression is strongly upregulated in neuroblastoma compared with normal tissues, adult malignancies, and non-malignant fetal adrenal neuroblasts. The over-expression of BIRC5 correlates with an unfavorable prognosis independent of the presence of 17q gain. Silencing of BIRC5 in neuroblastoma cell lines by various antisense molecules resulted in massive apoptosis as measured by PARP cleavage and FACS analysis. As both the intrinsic apoptotic pathway and the chromosomal passenger complex can be therapeutically targeted, we investigated in which of them BIRC5 exerted its essential anti-apoptotic role. Immunofluorescence analysis of neuroblastoma cells after BIRC5 silencing showed formation of multinucleated cells indicating mitotic catastrophe, which leads to apoptosis via P53 and CASP2. We show that BIRC5 silencing indeed resulted in activation of P53 and we could rescue apoptosis by CASP2 inhibition. We conclude that BIRC5 stabilizes the microtubules in the chromosomal passenger complex in neuroblastoma and that the apoptotic response results from mitotic catastrophe, which makes BIRC5 an interesting target for therapy.
Insights
Survivin (BIRC5) is upregulated in neuroblastoma, promoting cancer cell survival by stabilizing microtubules. Silencing BIRC5 triggers apoptosis via mitotic catastrophe, making it a promising therapeutic target for neuroblastoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Neuroblastoma often involves gain of chromosome 17q.
- BIRC5 (Survivin) is a key protein in apoptosis and microtubule stabilization.
- Overexpression of BIRC5 is implicated in various cancers.
Purpose of the Study:
- To investigate the role of BIRC5 in neuroblastoma.
- To determine the mechanism by which BIRC5 promotes neuroblastoma survival.
- To evaluate BIRC5 as a therapeutic target in neuroblastoma.
Main Methods:
- Analysis of Affymetrix mRNA expression data.
- Silencing of BIRC5 using antisense molecules in neuroblastoma cell lines.
- Assessment of apoptosis via PARP cleavage and FACS analysis.
- Immunofluorescence microscopy to analyze cellular morphology.
- Investigation of the involvement of P53 and CASP2 pathways.
Main Results:
- BIRC5 is significantly upregulated in neuroblastoma compared to normal tissues.
- High BIRC5 expression correlates with unfavorable prognosis, independent of 17q gain.
- BIRC5 silencing induced massive apoptosis in neuroblastoma cells.
- BIRC5 silencing led to multinucleated cells, indicating mitotic catastrophe.
- Apoptosis was mediated by P53 activation and CASP2, and could be rescued by CASP2 inhibition.
Conclusions:
- BIRC5 stabilizes microtubules within the chromosomal passenger complex in neuroblastoma.
- The anti-apoptotic role of BIRC5 in neuroblastoma is linked to mitotic catastrophe.
- BIRC5 is a potential therapeutic target for neuroblastoma treatment.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Extrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Abnormal Proliferation
Apoptosis
